Answer
Yes, gallstones have been reported during octreotide treatment and may be associated with gallbladder inflammation and bile duct dilatation; gallbladder ultrasound is recommended before treatment and at approximately 6–12-month intervals during therapy.
Sources for this answer
- Oczyesa 20 mg prolonged-release solution for injection in pre-filled penCamurus AB · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked